Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Euro Surveill ; 25(19)2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32431288

RESUMO

Using electronic health records, we assessed the early impact of coronavirus disease (COVID-19) on routine childhood vaccination in England by 26 April 2020. Measles-mumps-rubella vaccination counts fell from February 2020, and in the 3 weeks after introduction of physical distancing measures were 19.8% lower (95% confidence interval: -20.7 to -18.9) than the same period in 2019, before improving in mid-April. A gradual decline in hexavalent vaccination counts throughout 2020 was not accentuated by physical distancing.


Assuntos
Infecções por Coronavirus/epidemiologia , Coronavirus , Surtos de Doenças/prevenção & controle , Vacina contra Sarampo-Caxumba-Rubéola , Pandemias , Pneumonia Viral/epidemiologia , Vacinação/estatística & dados numéricos , Betacoronavirus , COVID-19 , Pré-Escolar , Inglaterra , Acessibilidade aos Serviços de Saúde , Humanos , Lactente , Sarampo/prevenção & controle , Caxumba/prevenção & controle , Quarentena , Rubéola (Sarampo Alemão)/prevenção & controle , SARS-CoV-2
2.
Sex Transm Infect ; 95(8): 608-613, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31028226

RESUMO

BACKGROUND: Human papillomavirus (HPV) vaccination for gay, bisexual and other men who have sex with men (GBMSM) aged up to 45 years attending sexual health clinics (SHC) and HIV clinics began in England as a pilot in June 2016, with national roll-out from April 2018. The recommended course is three doses of the quadrivalent HPV vaccine over one to 2 years. We present the methodology and results of monitoring vaccination uptake (initiation and completion), and attendance patterns, during the pilot phase. METHODS: Total numbers of eligible GBMSM receiving HPV vaccine doses were extracted from routine datasets from pilot start to end of March 2018. Numbers of attendances since January 2009 were extracted and tested for trends before and after introduction of HPV vaccination. RESULTS: Overall, first dose uptake was 49.1 % (23 619/48 095), with clinics with highest data completeness achieving close to 90% uptake during the pilot period. Refusals were very low (3.5%). There was no evidence of increases in the number of GBMSM attendances at pilot SHC. CONCLUSIONS: HPV vaccination has not caused important deviations to expected attendance patterns of GBMSM at SHC throughout the pilot phase. Overall, recorded initiation has been encouraging given known issues with data recording, as is current status of second and third dose completion. Attendances, vaccination initiation and completion will continue to be monitored alongside surveillance of anogenital warts diagnoses and of rectal HPV prevalence.


Assuntos
Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18/administração & dosagem , Imunização/métodos , Infecções por Papillomavirus/prevenção & controle , Minorias Sexuais e de Gênero , Cobertura Vacinal , Adolescente , Adulto , Inglaterra , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
3.
Euro Surveill ; 24(8)2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30808443

RESUMO

BACKGROUND: Opportunistic human papillomavirus (HPV) vaccination for men who have sex with men (MSM) was piloted in sexual health clinics (SHC) in England between 2016 and 2018. AIM: to evaluate the pilot's first year (April 2016-March 2017) in terms of feasibility, acceptability, uptake, impact and equity and interpret the outcome in the context of wide HPV vaccination policy. METHODS: Attendance and uptake data from routine SHC surveillance datasets and a cross-sectional survey administered to individuals receiving the vaccine were analysed. RESULTS: Among 18,875 eligible MSM, 8,580 (45.5%) were recorded as having received one HPV vaccine dose, decreasing slightly with increasing age, and uptake was higher in rural than urban areas. Survey results suggested that of those receiving the first dose of HPV vaccine, 8% were new attendees and that among those, less than 11% attended just to receive the vaccine. Of those having their first HPV vaccination, 95% indicated they would like to receive the next vaccine doses at the same clinic and 85% of patients reported accessing other services when visiting SHC for the first dose of vaccine. CONCLUSION: An opportunistic HPV vaccination programme for MSM can be delivered in an acceptable and, as far as can be evaluated, equitable manner, without major disruption to SHC and HIV clinics.


Assuntos
Instituições de Assistência Ambulatorial/estatística & dados numéricos , Conhecimentos, Atitudes e Prática em Saúde , Homossexualidade Masculina/estatística & dados numéricos , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/administração & dosagem , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Vacinação/estatística & dados numéricos , Adolescente , Adulto , Distribuição por Idade , Estudos Transversais , Estudos de Viabilidade , Humanos , Imunização , Masculino , Papillomaviridae , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/virologia , Avaliação de Programas e Projetos de Saúde , População Rural , População Urbana
4.
Vaccine ; 38(33): 5297-5304, 2020 07 14.
Artigo em Inglês | MEDLINE | ID: mdl-32561120

RESUMO

BACKGROUND: In England, coverage for childhood vaccines have decreased since 2012/13 in the context of an increasingly visible anti-vaccination discourse. We determined whether anti-vaccination sentiment is the likely cause of this decline in coverage. METHODS: Descriptive study triangulating a range of data sources (vaccine coverage, cross-sectional survey of attitudes towards vaccination, UK-specific Twitter social media) and assessing them against the following Bradford Hill criteria: strength of association, consistency, specificity, temporality, biological gradient and coherence. RESULTS: Strength of association: compared with well-documented vaccine scares, the decline in childhood vaccination seen since 2012/13 is 4-20 times smaller; consistency: while coverage for completed courses of the hexavalent and meningococcal vaccines decreased by 0.5-1.2 percentage points (pp) between 2017 and 2019, coverage for the first dose of these vaccines increased 0.5-0.7 pp; specificity: Since 2012-13, coverage decreased for some vaccines (hexavalent, MMR, HPV, shingles) and increased for others (MenACWY, Td/IPV, antenatal pertussis, influenza in 2 years of children), with no age-specific patterns. Temporality and biological gradient: the decline in vaccine coverage was preceded by an increase in vaccine confidence and a decrease in the proportion of parents encountering anti-vaccination materials. Coherence: attitudes towards vaccination expressed on Twitter in the UK became increasingly positive between 2017 and 2019 as vaccine coverage for childhood vaccines decreased. CONCLUSIONS: In England, trends in vaccine coverage between 2012/13 and 2018/19 were not homogenous and varied in magnitude and direction according to vaccine, dose and region. In addition, confidence in vaccines increased during the same period. These findings are not compatible with anti-vaccination sentiment causing a decline in vaccine coverage In England.


Assuntos
Mídias Sociais , Vacinação , Criança , Estudos Transversais , Inglaterra , Feminino , Humanos , Pais , Gravidez
5.
Vaccine ; 37(36): 5218-5224, 2019 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-31351797

RESUMO

The process of obtaining informed consent for school-based adolescent immunisation provides an opportunity to engage families. However, the fact that parental consent needs to be obtained remotely adds complexity to the process and can have a detrimental effect on vaccine uptake. We conducted a multiple methods analysis to examine the practice of obtaining informed consent in adolescent immunisation programmes. This involved a thematic analysis of consent related data from 39 interviews with immunisation managers and providers collected as part of a 2017 service evaluation of the English adolescent girls' HPV vaccine programme and a descriptive statistical analysis of data from questions related to consent included in a 2017 survey of parents' and adolescents' attitudes to adolescent vaccination. The findings indicated that the non-return of consent forms was a significant logistical challenge for immunisation teams, and some were piloting opt-out consent mechanisms, increasing the proportion of adolescents consenting for their own immunisations, and introducing electronic consent. Communicating vaccine related information to parents and schools and managing uncertainties about obtaining adolescent self-consent for vaccination were the main practical challenges encountered. Survey data showed that parents and adolescents generally agreed on vaccine decisions although only 32% of parents discussed vaccination with their teenager. Parental awareness about the option for adolescents to self-consent for vaccination was limited and adolescents favoured leaving the decision-making to parents. From the interviews and variability of consent forms it was evident that health professionals were not always clear about the best way to manage the consent process. Some were also unfamiliar with self-consent processes and lacked confidence in assessing for 'Gillick competency'. Developing pathways and related interventions to improve the logistics and practice of consent in school-based adolescent immunisation programmes could help improve uptake.


Assuntos
Programas de Imunização/estatística & dados numéricos , Vacinação/estatística & dados numéricos , Adolescente , Tomada de Decisões , Feminino , Humanos , Masculino , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/uso terapêutico , Consentimento dos Pais , Instituições Acadêmicas/estatística & dados numéricos , Inquéritos e Questionários
6.
Papillomavirus Res ; 8: 100183, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31476478

RESUMO

The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.


Assuntos
Pessoal de Saúde , Papillomaviridae/imunologia , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/imunologia , Europa (Continente)/epidemiologia , Conhecimentos, Atitudes e Prática em Saúde , Implementação de Plano de Saúde , Humanos , Infecções por Papillomavirus/complicações , Infecções por Papillomavirus/virologia , Vacinas contra Papillomavirus/administração & dosagem , Serviços Preventivos de Saúde , Vigilância em Saúde Pública , Vacinação
7.
Hum Vaccin Immunother ; 14(1): 179-188, 2018 01 02.
Artigo em Inglês | MEDLINE | ID: mdl-29048989

RESUMO

OBJECTIVE: To examine amongst healthcare professionals in England; knowledge of vaccinations in pregnancy, their perceived roles in these programmes and whether they recommend scheduled vaccines to pregnant women. DESIGN: Cross sectional survey (online questionnaire) Setting: Healthcare workers in contact with pregnant women in England. PARTICIPANTS: The survey analysis included 3441 healthcare workers who had been surveyed during May to August 2015. The participants were midwives, practice nurses and health visitors, working in England who were members of the Royal College of Midwives, Royal College of Nursing and the Institute of Health Visiting. RESULTS: We found that knowledge of vaccination in pregnancy was high in all professional groups. Seventy three percent of all respondents would recommend the influenza vaccine and 74% would recommend the pertussis vaccine to pregnant women. They were more likely to recommend vaccination in pregnancy if they would personally have the influenza and pertussis vaccines themselves and/or if they had the influenza vaccine as a healthcare worker. Practice nurses were significantly more likely to recommend the pertussis and influenza vaccines to pregnant women than midwives and health visitors. Health professionals who had received immunisation training were more confident in giving advice to pregnant women. CONCLUSION: Immunisation training is essential if healthcare workers are to be informed and confident in effectively delivering the maternal immunisation programme and thus improving uptake of vaccines in pregnancy. These findings are important in tailoring educational programmes and addressing the training needs of different healthcare professional groups.


Assuntos
Atitude do Pessoal de Saúde , Tocologia , Enfermeiros de Saúde Comunitária/psicologia , Complicações Infecciosas na Gravidez/prevenção & controle , Vacinação/psicologia , Adulto , Idoso , Estudos Transversais , Inglaterra , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Vacinas contra Influenza/uso terapêutico , Influenza Humana/prevenção & controle , Influenza Humana/virologia , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Vacina contra Coqueluche/uso terapêutico , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Cuidado Pré-Natal/psicologia , Inquéritos e Questionários , Coqueluche/microbiologia , Coqueluche/prevenção & controle , Adulto Jovem
8.
BMJ Open ; 7(4): e012851, 2017 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-28473508

RESUMO

OBJECTIVES: (1) To explore existing knowledge of, and attitudes, to group B meningococcal disease and serogroup B meningococcal (MenB) vaccine among parents of young children. (2) To seek views on their information needs. DESIGN: Cross-sectional qualitative study using individual and group interviews conducted in February and March 2015, prior to the introduction of MenB vaccine (Bexsero) into the UK childhood immunisation schedule. SETTING: Community centres, mother and toddler groups, parents' homes and workplaces in London and Yorkshire. PARTICIPANTS: 60 parents of children under 2 years of age recruited via mother and baby groups and via an advert posted to a midwife-led Facebook group. RESULTS: Although recognising the severity of meningitis and septicaemia, parents' knowledge of group B meningococcal disease and MenB vaccine was poor. While nervous about fever, most said they would take their child for MenB vaccination despite its link to fever. Most parents had liquid paracetamol at home. Many were willing to administer it after MenB vaccination as a preventive measure, although some had concerns. There were mixed views on the acceptability of four vaccinations at the 12-month booster visit; some preferred one visit, while others favoured spreading the vaccines over two visits. Parents were clear on the information they required before attending the immunisation appointment. CONCLUSIONS: The successful implementation of the MenB vaccination programme depends on its acceptance by parents. In view of parents' recognition of the severity of meningitis and septicaemia, and successful introduction of other vaccines to prevent bacterial meningitis and septicaemia, the MenB vaccination programme is likely to be successful. However, the need for additional injections, the likelihood of post-immunisation fever and its management are issues about which parents will need information and reassurance from healthcare professionals. Public Health England has developed written information for parents, informed by these findings.


Assuntos
Febre/tratamento farmacológico , Programas de Imunização , Meningite Meningocócica/prevenção & controle , Vacinas Meningocócicas/farmacologia , Pais/psicologia , Saúde Pública , Acetaminofen/uso terapêutico , Adulto , Ansiedade , Estudos Transversais , Inglaterra/epidemiologia , Estudos de Avaliação como Assunto , Feminino , Febre/induzido quimicamente , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Lactente , Masculino , Meningite Meningocócica/epidemiologia , Meningite Meningocócica/imunologia , Pais/educação , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Educação de Pacientes como Assunto
9.
Vaccine ; 35(22): 2979-2985, 2017 05 19.
Artigo em Inglês | MEDLINE | ID: mdl-28442229

RESUMO

OBJECTIVES: We undertook a national survey of parental attitudes to childhood vaccinations and compared results with those in earlier comparable surveys covering a 10year period. METHODS: We randomly selected 275 nationally representative sampling locations in England. Interviewers identified eligible primary care givers (referred to as parents) of children aged from 2months to <5years and conducted home-based interviews between January and April 2015. We aimed to recruit 1000 parents of children aged 0-2years and 1000 of children aged 3-4years. The questionnaire covered all aspects of the immunisation process, vaccines administered in pregnancy and from infancy to pre-school with a maximum of 86 mixed questions. RESULTS: Interviews were completed with 1792 parents of whom 1130 had children aged 0-2years and 999 had children aged 3-4years; 337 had children of both ages. The findings showed that confidence in and acceptance of the vaccination programme was high. Only 2% of parents reported refusing vaccination whilst 90% reported vaccinating their children automatically when due. Almost all parents (97%) had access to the internet and 34% consulted web-based resources for information on vaccination. Parents who used chat rooms or discussion forums for this purpose were significantly more likely to say they had seen something that would make them doubt having their child(ren) immunised (31% compared to 8% amongst all parents). Health professionals and the NHS were seen as the most trusted source of advice on immunisation (90% agreed/strongly agreed with each). Very few parents did not trust these sources (4% and 3% disagreed, respectively). CONCLUSIONS: Health professionals remain extremely important in communicating information about vaccination and are highly trusted by parents; a trust that has increased in recent years. Despite most parents seeking information on the Internet, trust in and advice from health care professionals appeared to be key factors influencing parental decisions.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde/etnologia , Imunização/psicologia , Pais/psicologia , Adolescente , Adulto , Pré-Escolar , Inglaterra , Feminino , Pessoal de Saúde , Humanos , Programas de Imunização , Lactente , Recém-Nascido , Internet , Masculino , Gravidez , Inquéritos e Questionários , Adulto Jovem
10.
Papillomavirus Res ; 4: 45-53, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29179869

RESUMO

The Human Papillomavirus Prevention and Control Board brought together experts to discuss optimizing HPV vaccination and screening programs. Board members reviewed the safety profile of licensed HPV vaccines based on clinical and post-marketing data, reaching a consensus that current safety data is reassuring. Successful vaccination programs used well-coordinated communication campaigns, integrating (social) media to spread awareness. Communication of evidence supporting vaccine effectiveness had beneficial effects on the perception of the vaccine. However, anti-vaccination campaigns have threatened existing programs in many countries. Measurement and monitoring of HPV vaccine confidence over time could help understand the nature and scale of waning confidence, define issues and intervene appropriately using context-specific evidence-based strategies. Finally, a broad group of stakeholders, such as teachers, health care providers and the media should also be provided with accurate information and training to help support prevention efforts through enhanced understanding of the risks and benefits of vaccination. Similarly, while cervical cancer screening through population-based programs is highly effective, barriers to screening exist: awareness in countries with population-based screening programs, access for vulnerable populations, and access and affordability in low- and middle-income countries. Integration of primary and secondary prevention has the potential to accelerate the decrease in cervical cancer incidence.


Assuntos
Detecção Precoce de Câncer , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/efeitos adversos , Vacinação/estatística & dados numéricos , Comunicação , Feminino , Pessoal de Saúde , Humanos , Programas de Imunização , Programas de Rastreamento , Papillomaviridae/imunologia , Infecções por Papillomavirus/epidemiologia , Vacinas contra Papillomavirus/administração & dosagem , Vacinas contra Papillomavirus/imunologia , Vacinação/efeitos adversos , Vacinação/psicologia
11.
Vet Microbiol ; 117(1): 71-4, 2006 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-16854535

RESUMO

The childhood immunisation programme in England aims to achieve and maintain high vaccine coverage so that no child needlessly suffers from a vaccine preventable disease. As part of the programme, parents must have appropriate support from health professionals and have information available to them to make informed decisions about their choices. Even though immunisation is voluntary in England, coverage is generally high. It has been estimated that only 0.33% of parents do not consent to their child being included in a computerised database that schedules immunisation appointments. Parental attitudes, experiences and social grade are influential in determining whether a child receives a vaccine. Personal experience and knowledge of diseases influence parental perceptions about the seriousness of diseases and their likelihood of being affected by it. In societies where immunisation programmes have been successful, the challenge is maintaining high levels of vaccine coverage. In the absence of disease, the threat of that disease rapidly disappears and anxieties about the vaccine's safety may increase. A fall in vaccine coverage can lead to the return of disease as happened in the UK when rates of pertussis immunisation plummeted in the 1970s. Further perceived threats may also affect vaccine uptake, for example, the MMR controversy dating from 1998. The article outlines the MMR debate in the UK, the communication of risk and benefit and the management of information to the public. It will share lessons learned and examine how they might apply to the veterinary programme.


Assuntos
Atitude Frente a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Vacinas/administração & dosagem , Vacinas/efeitos adversos , Medicina Veterinária/normas , Animais , Comunicação , Educação em Saúde/métodos , Promoção da Saúde/métodos , Humanos , Meios de Comunicação de Massa , Medição de Risco , Vacinação
13.
Vaccine ; 28(35): 5731-7, 2010 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-20558250

RESUMO

The paper presents the first results from the European project VACSATC which aimed to track parental attitudes on vaccinations across several European countries. We compared five cross-sectional surveys of parents with children less than 3 years of age in England, Norway, Poland, Spain and Sweden carried out during 2008-2009. Data were collected from 6611 respondents. Two countries used face-to face interviews, one used telephone interviews, and two other countries used mail-in questionnaires. In all countries health professionals were indicated as the most important and trusted source of information on vaccination. The study results also show that parental attitudes on vaccinations in the childhood vaccination programs are generally positive. However, there were differences in attitudes on vaccination between the five countries, possibly reflecting different methods of sampling the respondents, context-specific differences (e.g. level of activity of governmental agencies), but also individual-level parental variation in demographic and socioeconomic status variables.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Pais/psicologia , Vacinação/estatística & dados numéricos , Adolescente , Adulto , Pré-Escolar , Estudos Transversais , Europa (Continente) , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Lactente , Entrevistas como Assunto , Masculino , Inquéritos e Questionários , Adulto Jovem
14.
Vaccine ; 25(20): 3996-4002, 2007 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-17395344

RESUMO

This paper presents the findings of surveys that have tracked mothers' attitudes towards MMR over the period 1996-2006. The main aim was to demonstrate how attitudes in relation to MMR have evolved over the last 10 years incorporating the periods of time before, during and after the height of the MMR controversy within the UK. MMR vaccine remains the number one 'top of mind' vaccination issue for parents. The proportion of parents believing MMR to be a greater risk than the diseases it protects against has fallen from 24% in 2002 to 14% in 2006. The proportion of 'hard-core rejectors' of MMR vaccine remains stable at 6%. There has been a gradual and sustained increase in the proportion of parents across all social groups saying MMR was completely safe/slight risk rising from 60% in 2002 to a current level of 74%. There now appears to be a sustained move away from fears over MMR safety and belief in the unfounded link to autism towards a more positive perception of the vaccine.


Assuntos
Vacina contra Sarampo-Caxumba-Rubéola/administração & dosagem , Mães/psicologia , Vacinação/psicologia , Atitude Frente a Saúde , Pré-Escolar , Feminino , Humanos , Lactente , Entrevistas como Assunto , Vacina contra Sarampo-Caxumba-Rubéola/efeitos adversos , Inquéritos e Questionários
15.
Hum Vaccin ; 2(6): 243-8, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17102643

RESUMO

The introduction of a vaccine against human papillomavirus (HPV), a sexually transmitted virus that is the causal factor of at least 95% of invasive cervical cancer, could significantly reduce the number of cases of cervical cancer occurring in the UK each year. To ensure that individuals are protected before onset of sexual activity, it is likely that the vaccine will be offered to children around 10 years of age. It is important that parents' attitudes to HPV vaccination are taken into account, particularly as the subject relates to sexual health issues. In order to gauge parents' initial responses to the addition of HPV vaccine to the immunisation programme and identify the issues needing further research, in-depth interviews were held with parents of girls and boys aged 8-10 years. Our results show that most parents have not heard of HPV and were not aware of the role of HPV in cervical cancer. There were concerns about offering a vaccine that protects against a sexually transmitted infection to children and that the vaccine should be offered at an older age in conjunction with a sex education program. In order to avoid rejection of this vaccine, work needs to take place now to raise awareness of HPV as a cause of cervical cancer prior to any introduction of the vaccination program.


Assuntos
Atitude Frente a Saúde , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/administração & dosagem , Pais , Doenças Virais Sexualmente Transmissíveis/prevenção & controle , Neoplasias do Colo do Útero/prevenção & controle , Adulto , Criança , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Consentimento dos Pais , Aceitação pelo Paciente de Cuidados de Saúde , Vacinação
16.
Vaccine ; 23(48-49): 5670-87, 2005 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-16243412

RESUMO

This report presents the findings from a series of 20 surveys carried out between 1991 and 2001. The main objectives of the research were to: This unique body of more than 15,000 interviews was conducted as part of a routine programme of research supporting the national immunisation programme in England. These surveys show that the public wants clarity, consistency, factual information and openness from those delivering immunisation services.


Assuntos
Atitude Frente a Saúde , Serviços de Saúde da Criança/estatística & dados numéricos , Mães/psicologia , Vacinação/psicologia , Criança , Serviços de Saúde da Criança/normas , Pré-Escolar , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Programas de Imunização/organização & administração , Lactente , Recém-Nascido , Avaliação de Programas e Projetos de Saúde , Inquéritos e Questionários , Vacinação/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA